MedPath

DONNAGEL LIQ

DONNAGEL LIQ

Discontinued
DIN Number

02041774

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02041774
AIG Number0502288001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A07BC52 KAOLIN, COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (5)

ATROPINE SULFATEActive
Strength: 0.0194 MG / 30 ML
Monograph: ATROPINE SULFATE
HYOSCYAMINE SULFATEActive
Strength: 0.1037 MG / 30 ML
Monograph: HYOSCYAMINE SULFATE
KAOLINActive
Strength: 6 G / 30 ML
Monograph: KAOLIN
PECTINActive
Strength: 142.8 MG / 30 ML
Monograph: PECTIN
SCOPOLAMINE HYDROBROMIDEActive
Strength: 6.5 MCG / 30 ML
Monograph: SCOPOLAMINE HYDROBROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.